Newscenter Media News Elon Musk’s brain-chip startup, Neuralink, has received the US Food and Drug Administration’s “breakthrough device” designation for the company’s experimental implant, Blindsight. The device, called ‘Blindsight,’ is designed to restore vision in individuals with complete or partial blindness, including those with non-functional optic nerves. “We have received Breakthrough Device Designation from the FDA for Blindsight.
Check Also
Obasanjo demands new INEC leadership to restore electoral integrity
Former President Olusegun Obasanjo has called for the appointment of a credible leadership of the …